Success Story: NIW Approval Secured for a Biomedical Engineering Researcher With Our Expert Filing and Strategic Guidance
Client’s Testimonial:
"I’m truly grateful to the entire team. It was a pleasure working with you, and I really appreciate all the support throughout the process.”
On July 10th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Research Assistant
Country of Origin: Turkey
State of Residence at the Time of Filing: Illinois
Approval Notice Date: July 10th, 2026
Processing Time: 2 months, 20 days (Premium Processing Upgrade Requested)
Case Summary:
The National Interest Waiver (NIW) is intended for professionals whose work offers substantial merit and national importance to the United States. In this case, the client qualified by demonstrating a strong record of research in biomedical engineering and a clear plan to continue developing artificial intelligence- and machine learning-based technologies that improve automated insulin delivery systems. Holding an M.S. in mechanical engineering, the client proposed to advance precision medicine by creating safer, more effective approaches for personalized glucose control, with the broader goal of improving diabetes management on a national scale. Throughout the preparation of the petition, our team at North America Immigration Law Group (Chen Immigration Law Associates) focused on presenting both the national significance of the proposed research and the client's ability to continue making meaningful contributions in this area.
Rather than relying solely on academic metrics, we demonstrated how the client's research had already begun influencing the field. At the time of filing, the client had authored 4 peer-reviewed journal articles, 3 peer-reviewed conference papers, and 1 first-authored book chapter. The published work had received 36 citations, indicating that other researchers had begun building upon these contributions. We also highlighted that one publication had achieved exceptionally strong citation performance relative to other engineering papers from the same publication year, helping illustrate that the client's research attracted attention because of its technical value rather than simply the passage of time. In addition, the client had completed at least 10 peer reviews for recognized journals and conferences, reflecting that experts in the field trusted the client's technical judgment to evaluate the work of other researchers.
To further establish that the client was well positioned to advance the proposed endeavor, we emphasized both the quality of the research portfolio and its practical significance. The petition explained how the client's work integrates control engineering, machine learning, and biomedical systems to develop safer automated insulin delivery technologies and more personalized diabetes management tools. We also demonstrated that this research aligned with important U.S. public health priorities and that it had attracted support through major funding sources, including the National Institute of Diabetes and Digestive and Kidney Diseases and the Walder Foundation. Rather than presenting these facts in isolation, we connected them to the broader conclusion that independent experts and research sponsors recognized the importance of the client's ongoing work.
By carefully organizing the evidence under the Dhanasar framework, we showed that the client's proposed research carries broad public health benefits while the client's scholarly achievements demonstrate the capability to continue advancing this important field. We are delighted that USCIS approved the client's I-140 National Interest Waiver petition and wish the client continued success in developing innovative technologies that improve diabetes care and personalized medicine in the United States.